Savara (SVRA)
(Delayed Data from NSDQ)
$4.09 USD
-0.02 (-0.49%)
Updated May 31, 2024 04:00 PM ET
After-Market: $4.08 -0.01 (-0.24%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Savara Inc. [SVRA]
Reports for Purchase
Showing records 41 - 48 ( 48 total )
Company: Savara Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Savara Inc.
Industry: Medical - Biomedical and Genetics
Company: Savara Inc.
Industry: Medical - Biomedical and Genetics
KOL Dinner Highlights Molgradex and AeroVanc Potential
Provider: Roth Capital Partners, Inc.
Analyst: HIGGINS M
Company: Savara Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Savara Inc.
Industry: Medical - Biomedical and Genetics
Aironite Trial Completes Enrollment, on Track for 1H?18 Data
Provider: Roth Capital Partners, Inc.
Analyst: HIGGINS M
Company: Savara Inc.
Industry: Medical - Biomedical and Genetics
Company: Savara Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Savara Inc.
Industry: Medical - Biomedical and Genetics
Re-Initiation of Coverage - Breathing It All In; Re-Establishing Estimates with Buy and $40 PT
Provider: Roth Capital Partners, Inc.
Analyst: HIGGINS M